TheraRadar
← Back
Data updated: Mar 29, 2026

AJENAT PHARMS

OncologyGastroenterologyInfectious Disease
Big Pharma

AJENAT PHARMS is a major pharmaceutical company focused on Oncology, Gastroenterology, Infectious Disease.

1943
Since
16
Drugs
-
Trials
336
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

GABAPENTIN 2026-02-24
Labeling
GABAPENTIN 2026-02-18
Labeling
GABAPENTIN 2026-02-17
Labeling
GABAPENTIN 2026-02-17
Labeling
GABAPENTIN 2026-02-12
Labeling
GLYCOPYRROLATE 2026-02-10
Labeling
GLYCOPYRROLATE 2026-02-06
Labeling
GABAPENTIN 2026-01-29
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 25%
1 drugs
Gastroenterology 25%
1 drugs
Infectious Disease 25%
1 drugs
Dermatology 25%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Oncology, Dermatology
Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology, Infectious Disease
CASPER PHARMA LLC big-pharma
Infectious Disease, Oncology, Gastroenterology, Dermatology
COSETTE other
Dermatology, Infectious Disease, Oncology